Sleep and insulin-like growth factors in the cardiovascular health study

Journal of Clinical Sleep Medicine

Volumn 9, Issue 12, 2013, Pages 1245-1251

  Shah, Neomi ^a,d   Rice, Tom ^b   Tracy, Daniel ^a   Rohan, Thomas ^a   Bůžková, Petra ^c   Newman, Anne ^b   Kaplan, Robert C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Elderly; GH IGF axis; IGF; IGFBP 3; Insulin like growth factors; Sleep; Sleep apnea; Slow wave sleep

Indexed keywords

ESTROGEN; GESTAGEN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGED; AROUSAL; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PROTEIN FUNCTION; RACE; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SLEEP PARAMETERS; SLEEP TIME; SLOW WAVE SLEEP;

ELDERLY; GH/IGF AXIS; IGF; IGFBP-3; INSULIN-LIKE GROWTH FACTORS; SLEEP; SLEEP APNEA; SLOW WAVE SLEEP;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GERIATRIC ASSESSMENT; HEALTH SURVEYS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; SEX DISTRIBUTION; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SOMATOMEDINS; UNITED STATES;

EID: 84890322024     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.3260     Document Type: Article

References (38)

1. Faje AT, Barkan AL. Basal, but not pulsatile, growth hormone secretion determines the ambient circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 2010;95:2486-91.
2. Biernacka KM, Perks CM, Holly JM. Role of the IGF axis in prostate cancer. Minerva Endocrinol 2012;37:173-85.
3. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939-44.
4. Empen K, Lorbeer R, Volzke H, et al. Association of serum insulin-like growth factor I with endothelial function: Results from the population-based Study of Health in Pomerania (SHIP). Eur J Endocrinol 2010;163:617-23.
5. Gianotti L, Pivetti S, Lanfranco F, et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 2002;87:5052-7.
6. Johnsen SP, Hundborg HH, Sorensen HT, et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005;90:5937-41.
7. Ursavas A, Karadag M, Ilcol YO, et al. Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome. Lung 2007;185:309-14.
8. Sherlock M, Toogood AA. Aging and the growth hormone/insulin like growth factor-I axis. Pituitary 2007;10:189-203.
9. Chu LW, Zhu Y, Yu K, et al. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev 2008;17:3268-73.
10. Amaral IP, Johnston IA. Circadian expression of clock and putative clock-controlled genes in skeletal muscle of the zebrafish. Am J Physiol Regul Integr Comp Physiol 2012;302:R193-206.
11. Chen W, Salojin KV, Mi QS, et al. Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 2004;145:627-38.
12. Friedrich N, Schneider H, Dorr M, et al. All-cause mortality and serum insulin-like growth factor I in primary care patients. Growth Horm IGF Res 2011;21:102-6.
13. Rajpathak SN, He M, Sun Q, et al. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes 2012;61:2248-54.
14. Burgers AM, Biermasz NR, Schoones JW, et al. Meta-analysis and doseresponse metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab 2011;96:2912-20.
15. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006;29:657-61.
16. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010;137:95-101.
17. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ, International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008;81:2-12.
18. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
19. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003;26:702-9.
20. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009;122:1122-7.
21. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590-5.
22. Anisimov VN, Bartke A. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer. Crit Rev Oncol Hematol 2013;87:201-23.
23. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 2013;9:366-76.
24. Vitale G, Brugts MP, Ogliari G, et al. Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring. Aging (Albany NY) 2012;4:580-9.
25. Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med 2004;164:406-18.
26. Krishnan V, Collop NA. Gender differences in sleep disorders. Curr Opin Pulm Med 2006;12:383-9.
27. Van Cauter E. Slow wave sleep and release of growth hormone. JAMA 2000;284:2717-8.
28. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 1996;19(10 Suppl):S221-4.
29. Veldhuis JD. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 1996;134:287-95.
30. Redline S, Sanders MH, Lind BK, et al. Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep 1998;21:759-67.
31. Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997;20:1077-85.
32. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968.
33. Sanders JL, Ding V, Arnold AM, et al. Do changes in circulating biomarkers track with each other and with functional changes in older adults? J Gerontol A Biol Sci Med Sci 2013 June 28. [Epub ahead of print].
34. Taylor HL, Jacobs DR,Jr, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-55.
35. Folsom AR, Jacobs DR,Jr, Caspersen CJ, Gomez-Marin O, Knudsen J. Test-retest reliability of the Minnesota Leisure Time Physical Activity Questionnaire. J Chronic Dis 1986;39:505-11.
36. Van Cauter E, Copinschi G. Interrelationships between growth hormone and sleep. Growth Horm IGF Res 2000;10 Suppl B:S57-62.
37. Van Cauter E, Latta F, Nedeltcheva A, et al. Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 2004;14 Suppl A:S10-7.
38. Prinz PN, Moe KE, Dulberg EM, et al. Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men. J Gerontol A Biol Sci Med Sci 1995;50:M222-6.